This inventor holds 12 USPTO granted patents. Top assignees: Axiom Biotechnologies, Inc., Alla Chem, LLC, Albert Einstein College of Medicine. Active years: 1998-2021.
Company Filing History:
7 out of 8 
2 out of 3 
1 out of 513 
Years Active: 1998-2021
Title: Ilya Okun: Innovator in Pharmaceutical Research
Introduction
Ilya Okun is a prominent inventor based in San Diego, California, known for his significant contributions to pharmaceutical research. With a total of 12 patents to his name, he has made strides in developing innovative treatments for various medical conditions.
Latest Patents
Among his latest patents, Ilya Okun has developed PAK1 inhibitors and methods for treating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). These methods utilize compounds that inhibit the p21 protein (Cdc42/Rac)-activated kinase (PAK1). Another notable invention involves substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, which are antagonists of serotonin 5-HT receptors. These compounds regulate the homeostasis of calcium ions in cells and are represented by a specific general formula. The invention also includes methods for their production, pharmaceutical compositions, and their various uses.
Career Highlights
Ilya Okun has worked with several companies throughout his career, including Axiom Biotechnologies, Inc. and Alla Chem, LLC. His work in these organizations has contributed to advancements in biotechnological applications and pharmaceutical innovations.
Collaborations
Ilya has collaborated with notable individuals in his field, including Alex Okun and Sergey Yevgenievich Tkachenko. These collaborations have further enhanced his research and development efforts.
Conclusion
Ilya Okun's innovative work in pharmaceutical research and his numerous patents highlight his significant impact on the field. His contributions continue to pave the way for new treatments and advancements in medical science.